Table S1.
Comparison of the prevalence of each nonmotor symptom with other studies
| Current study (%) | Martinez- Martin et al1 (%) | P-value (χ2 test) | Chaudhuri et al2 (%) | P-value (χ2 test) | Gan et al3 (%) | P-value (χ2 test) | |
|---|---|---|---|---|---|---|---|
| Dribbling | 27.14 | 41.52 | 0.026* | 35 | 0.14 | 17.70 | 0.128 |
| Taste/smelling | 16.19 | 28.95 | 0.028* | 26 | 0.054 | 22.20 | 0.279 |
| Swallowing | 29.52 | 28.38 | 0.755 | 23.6 | 0.433 | 23.40 | 0.28 |
| Vomiting | 12.38 | 14.31 | 0.674 | 8.1 | 0.397 | 8.20 | 0.358 |
| Constipation | 50.95 | 52.48 | 0.887 | 46.7 | 0.831 | 64.60 | 0.036* |
| Bowel incontinence | 2.86 | 8.21 | 0.121 | 4.9 | 0.435 | 0.60 | 0.312 |
| Bowel emptying incomplete | 35.71 | 29.90 | 0.367 | 27.6 | 0.308 | 15.20 | 0.001* |
| Urgency | 49.52 | 55.81 | 0.395 | 61 | 0.022* | 31.00 | 0.006* |
| Nocturia | 62.86 | 61.90 | 0.884 | 66.7 | 0.116 | 61.40 | 0.84 |
| Pains | 22.86 | 28.76 | 0.333 | 27.6 | 0.225 | 27.20 | 0.487 |
| Weight | 16.67 | 18.29 | 0.852 | 22 | 0.25 | 22.20 | 0.353 |
| Memory | 38.10 | 44.85 | 0.315 | 43.9 | 0.169 | 65.80 | <0.001* |
| Loss of interest | 26.19 | 34.67 | 0.167 | 29.3 | 0.425 | 48.70 | <0.001* |
| Hallucinations | 13.33 | 22.52 | 0.066 | 19.5 | 0.143 | 11.40 | 0.663 |
| Concentrating | 27.14 | 45.71 | 0.005* | 37.4 | 0.03* | 38.00 | 0.097 |
| Sadness/blues | 30.00 | 50.10 | 0.004* | 44.7 | 0.018* | 36.70 | 0.228 |
| Anxiety | 25.71 | 45.33 | 0.005* | 39.9 | 0.011* | 30.40 | 0.471 |
| Sex drive | 24.29 | 34.17 | 0.119 | 29.3 | 0.073 | 16.50 | 0.296 |
| Sex difficulty | 23.33 | 32.43 | 0.154 | 24.4 | 0.166 | 12.00 | 0.064 |
| Dizzy | 34.76 | 37.14 | 0.768 | 39.8 | 0.308 | 16.50 | 0.004* |
| Falling | 13.81 | 28.00 | 0.015* | 30.9 | 0.002* | 25.90 | 0.031* |
| Daytime sleepiness | 12.86 | 31.11 | 0.002* | 28.4 | 0.005* | 38.60 | <0.001* |
| Insomnia | 37.14 | 45.71 | 0.196 | 40.6 | 0.414 | 39.20 | 0.728 |
| Vivid dreams | 39.52 | 33.90 | 0.38 | 30.9 | 0.31 | 43.70 | 0.486 |
| RBD | 35.24 | 35.69 | 0.883 | 32.5 | 0.927 | 27.80 | 0.332 |
| Restless legs | 25.24 | 41.71 | 0.011* | 37.4 | 0.024* | 20.30 | 0.419 |
| Swelling | 14.29 | 31.30 | 0.004* | 30.9 | 0.001* | 8.20 | 0.183 |
| Sweating | 10.48 | 29.90 | <0.001* | 25.2 | 0.002* | 28.50 | 0.001* |
| Diplopia | 12.86 | 20.00 | 0.182 | 21.9 | 0.065 | 5.70 | 0.096 |
| Delusions | 6.19 | 11.07 | 0.205 | 12.3 | 0.11 | 12.00 | 0.132 |
Notes:
Indicates statistical significance. Adapted with permission from Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Movement Disorders. 2007;22(11):1623–1629. Published by John Wiley and Sons. Copyright © 2007 Movement Disorder Society.1 And adapted with permission from Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Movement Disorders. 2006;21(7):916–923. Published by John Wiley and Sons. Copyright © 2006 Movement Disorder Society.2 And adapted from Journal of Clinical Neuroscience. 2014;21(5). Gan J, Zhou M, Chen W, Liu Z. Non-motor symptoms in Chinese Parkinson’s disease patients. 751–754. With permission from Elsevier. Copyright © 2013 Elsevier Ltd. All rights reserved.3
Abbreviation: RBD, rapid eye movement sleep behavior disorder.